ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1112

Relationship of Depth-Specific Subchondral Bone Mineral Density and Pain in Knee Osteoarthritis: The Multicenter Osteoarthritis Study

Jean Liew1, JD Johnston2, Na Wang3, John Lynch4, Cora Lewis5, James Torner6 and Tuhina Neogi3, 1University of Washington, Seattle, WA, 2University of Saskatchewan, Saskatoon, SK, Canada, 3Boston University School of Medicine, Boston, MA, 4UCSF, San Francisco, CA, 5University of Alabama Birmingham, Birmingham, AL, 6University of Iowa, Iowa City, IA

Meeting: ACR Convergence 2020

Keywords: Bone density, Epidemiology, Imaging, Osteoarthritis, pain

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2020

Title: Osteoarthritis – Clinical Poster I

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: OA has traditionally been considered a disease of cartilage but early OA changes in subchondral bone may precede cartilage abnormalities. Altered subchondral bone mineral density (BMD) is thought to lead to cartilage pathology through abnormal force transfer. This in turn may contribute to pain in OA. It is unclear whether BMD increases or decreases with OA, and/or what effect these changes may have on pain. CT topographic mapping of subchondral density (CT-TOMASD) is a 3D imaging tool that precisely measures subchondral cortical and trabecular BMD in relation to depth from the subchondral surface. The aim of this study was to evaluate compartment- and depth-specific subchondral BMD in relation to knee pain.

Methods: Participants from the Multicenter Osteoarthritis (MOST) study, a NIH-funded longitudinal prospective cohort of older adults with or at risk of knee OA, who had knee CTs and knee pain assessed were included in this cross-sectional analysis. Knee pain was measured as the mean pain in the past 30 days, scored on a visual analog scale (VAS) (range 0-100), and dichotomized at 40/100. CT-TOMASD was used to assess tibial subchondral BMD at depths of 0-2.5 mm, 2.5-5.0 mm, and 5-10 mm relative to the subchondral surface. Regional analyses of each medial and lateral plateau, at each depth were performed to calculate average BMD. We evaluated the relation of subchondral BMD to presence of knee pain using logistic regression with generalized estimating equations to account for 2 knees within individuals, for each compartment and depth in separate models, and adjusted for age, sex, and body mass index (BMI). We additionally adjusted for, and stratified by, radiographic OA (ROA) status in separate models.

Results: 2082 subjects were included (mean age 61.1±9.7, 56.5% female, mean BMI 28.8±5.2 kg/m2). The odds of having a VAS knee pain of ≥40/100 was significantly lower for a SD-unit increase in average subchondral BMD, after adjustment for age, sex, and BMI. This association was seen in both medial and lateral compartments though more marked within the medial compartment.  The magnitude of association did not differ for increasing depths beneath the subchondral surface. Analyses adjusting for, or stratifying by, ROA status did not differ substantially from the main results.

Conclusion: Lower subchondral tibial BMD measures were associated with higher knee pain scores in individuals with or at risk for knee OA. There were no clear differences noted with increasing depths beneath the subchondral surface that would support differential depth-specific contributions from subchondral BMD involved in the pathogenesis of pain in knee OA. These findings may reflect the stage of OA at which there may be high bone remodeling in response to abnormal joint loading, impact or injury, and may be worth exploring as a more timely stage of intervening for targeting OA-related pain. Further studies using CT-TOMASD will evaluate the association of these subchondral BMD measures, including effects of stress-shielding, and structural changes seen on MRI.  

Figure 1.


Disclosure: J. Liew, None; J. Johnston, Zimmer Biomet, Warsaw, IN, USA, 7, Advanced Technology in Orthopedics, Houston, TX, USA, 1; N. Wang, None; J. Lynch, None; C. Lewis, None; J. Torner, None; T. Neogi, Lilly, 1, EMD Merck Serono, 1, Novartis, 1, Regeneron, 1, Pfizer/Lilly, 1.

To cite this abstract in AMA style:

Liew J, Johnston J, Wang N, Lynch J, Lewis C, Torner J, Neogi T. Relationship of Depth-Specific Subchondral Bone Mineral Density and Pain in Knee Osteoarthritis: The Multicenter Osteoarthritis Study [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/relationship-of-depth-specific-subchondral-bone-mineral-density-and-pain-in-knee-osteoarthritis-the-multicenter-osteoarthritis-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/relationship-of-depth-specific-subchondral-bone-mineral-density-and-pain-in-knee-osteoarthritis-the-multicenter-osteoarthritis-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology